Cartagenia

OneSight is the first standalone commercial software for visualizing and exploring chromosomal aneuploidies from cell-free DNA in research contexts.

Agilent is buying Cartagenia to offer a complete suite of products for NGS and array testing that covers data generation through interpretation.

Agilent is buying the Belgium-based clinical software and services company for an undisclosed sum.

Under the terms of the agreement, customers of Cartagenia's Bench Lab NGS software will have access to N-of-One's clinical interpretation services.

Pathology laboratories using Cartagenia's Bench NGS software will be able to access MedGenome's annotated cancer variant database. 

NEW YORK (GenomeWeb) – CollabRx and Cartagenia have teamed up to provide an end-to-end software solution for clinical laboratories that supports genetic testing and reporting, including next-generation sequencing-based tests, in oncology.

NEW YORK (GenomeWeb) – Cartagenia announced today that it and Qiagen's bioinformatics business are part of a consortium that has received €1.4 million ($1.7 million) in funding from a European funding initiative to support the development of software tools for personalized genetic analysis of can

NEW YORK (GenomeWeb) – Cartagenia said this week that the National Institutes of Health's Undiagnosed Disease Program is using a customized version of its Bench Lab platform, a software solution for assessing and reporting on genetic variants, to analyze mutations that are identified in exome seq

NEW YORK (GenomeWeb) –Life science software firm BioDiscovery this week unveiled NXClinical, a new addition to its product portfolio that's tailored specifically for the clinical laboratory market and provides tools for analyzing, processing, and reporting the results of genetic tests.

NEW YORK (GenomeWeb) – Cartagenia said this week that it intends to use €4.3million ($5.9 million) in private financing to grow its business and to hire between 20 and 30 sales and support staff for its offices in Boston and Leuven, Belgium.

Pages

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.